Results

Total Results: 2,064 records

Showing results for "year".

401. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - This report is being generated twice a year. … (n=1,142) at increased risk of exacerbations received azithromycin 250 mg daily or placebo for 1 year … The frequency of exacerbations was 1.48 exacerbations per patient- year in the azithromycin group and … 1.83 per patient-year in the placebo group (p=0.01). … The hazard ratio (HR) for having an acute COPD exacerbation was 0.73 per patient-year (95% CI, 0.63

402. Critical Analysis of the Evidence for Patient Safety Practices in Nursing Home Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nursing-home-safety_research-protocol.pdf
     July 22, 2015 - minimal harm level, and 2% were considered to be an actual harm.2 An estimated mean 1.5 falls/bed/year

403. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting_research-protocol.pdf
     August 19, 2011 - ) and long-term (>1 year) outcomes, including: ○ Stent-related outcomes (restenosis, thrombosis, repeat … undergoing PCI, and improve short-term (in hospital or discharge to 30 days), intermediate (≥30 days to 1 year … ), and long-term (>1 year) outcomes. … They will be further categorized to specific epochs: in hospital, discharge to 30 days, >30 days to 1 year … , and >1 year.

404. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - This report is being generated twice a year. … In the 2-year cycle from 2009 to 2010, the age-adjusted obesity prevalence was about 36% among adult … The authors reported the following results:68 At 1 year, 55.4% of patients (883 of 1595) receiving … At 1 year, 47.5% of patients in the lorcaserin group and 20.3% in the placebo group had lost 5% or … year 2 (67.9%) than in patients who 17 received placebo during year 2 (50.3%, P<0.001).

405. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
     January 01, 2007 - Only nine studies compared ACEIs and ARBs for periods longer than 1 year.

406. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - health care system (e.g., patient outcomes, utilization, infrastructure, costs) is aggregated twice a year … This report is being generated twice a year.

407. Disposition of Comments Report for Comparative Effectiveness of Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
     June 05, 2013 - - At one year, surgery patients show significantly greater weight loss than can be expected from diets … why same BMI cut-off used for Asians (e.g Ramachandran trial) The BMI cut-off was decided during a year … for the following statement is not indicated: Postoperative BMI was much lower than the earlier one year … Studies that measured out to one year or more reported continued improvement in HbA1c values. … et al (page 143, line 3) and Carelli et al (Safety of the laparoscopic adjustable gastric band: 7-year

408. EHC Protocol: Making Healthcare Safer IV: Deprescribing to Reduce Medication Harms in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
     July 01, 2023 - Timing Original studies published from 2019 onwards, the year of the search done for the MHS III report … a single team member to confirm eligibility and prepare a summary of the study, including author, year … describe eligible systematic reviews, a single team member will prepare a summary including the author, year

409. Management of Infantile Hemangioma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_policymaker.pdf
     June 01, 2016 - Management of Infantile Hemangioma B A C K G R O U N D Infantile hemangioma (IH) is generally a benign vascular neoplasm. The International Society for the Study of Vascular Anomalies (ISSVA) classifies IH lesions as vascular tumors, which are differentiated from vascular malformations.2 IH affects 4 to 5 perce…

410. Behavioral Programs for Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
     September 11, 2015 - Time since diagnosis (≤1 year vs. >1 year) e. … Time since diagnosis (≤1 year vs. >1 year) e. … 11 to 26 hours (e.g., weekly for up to 6 months) 3. ≥27 hours (allowing for monthly followup for 1 year … Our exclusion criteria related to duration of diabetes (mean <1 year)—implemented in order to capture … complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year

411. Insulin Delivery and Glucose Monitoring Methods: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
     August 01, 2015 - Holman RR, Paul SK, Bethel MA, et al. 10- year follow-up of intensive glucose control in type 2 diabetes … Holman RR, Paul SK, Bethel MA, et al. 10- year follow-up of intensive glucose control in type 2 diabetes … 2012 (Final data collection date for primary outcome measure) Purpose: To compare, over a one-year

412. Disposition of Comments for Technical Brief 24 Resident Safety Practices (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
     May 27, 2016 - Disposition of Comments for Technical Brief 24 Resident Safety Practices Source: https://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productid=2224 Published Online: May 27, 2016 Technical Brief Disposition of Comments Report Research Review Title: Resident Saf…

413. Noninvasive Treatments for Low Back Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
     February 01, 2016 - When possible, timing of outcomes was stratified as long term (at least 1 year) and short term (up … Findings may be used for research purposes, but should not be considered current. 5 design, year, … difference between diazepam 5 mg twice daily for 5 days vs. placebo in function at 1 week through 1 year … or in other outcomes, including analgesic use, return to work, or likelihood of surgery through 1 year … 0.49 to 0.18; I2 = 0%), 3 to 6 months (2 trials; WMD, −0.20; 95% CI, −1.13 to 0.73; I2 = 81%), or 1 year

414. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - This report is being generated twice a year. … 1.7 million new cases of diabetes in U.S. people aged 20 years or older in 2012 (the most recent year … that the formulation of exenatide used in ITCA 650 is stable within the Duros pump for at least 1 year … In a trial (n=31) reporting 3-year followup in February 2013, Lanzarini and colleagues reported on … In August 2011, Pearson and colleagues published 3-year results from a 4-year, multicenter, randomized

415. Cannabis-2022-Surv-Rep-3-Table-F5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
     January 01, 2022 - Cannabis cohort studies PMID Author, Year Study Design Setting Pain Population Pain Condition Age Measure … Australia Chronic non-cancer pain Mixed Mean 58 56 NR NR NR NR NR Median 120 NR Overall N Baseline: 1,514 4-year … Daily or weekly use of marijuana B: Monthly or 1-2 times a month use of marijuana C: No use NR 52 (1 year

416. Cannabis-2022-Update-Surv-Rep-1-App-F-5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
     January 01, 2022 - Cannabis cohort studies PMID Author, Year Study Design Setting Pain Population Pain Condition Age Measure … Australia Chronic non-cancer pain Mixed Mean 58 56 NR NR NR NR NR Median 120 NR Overall N Baseline: 1,514 4-year … Daily or weekly use of marijuana B: Monthly or 1-2 times a month use of marijuana C: No use NR 52 (1 year

417. S23 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
     October 01, 2007 - information as 4.1 additional strokes per 100,000 women taking OC or 1 additional ischemic stroke per year … doctor–patient interaction after the evidence for HRT changed substantially.18,19 Clara S, a widowed 48-year-old

418. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - This report is being generated twice a year. … pharmacies range from about $400 to $415 per month or about $4,800 per year, all with the use of a … pharmacies ranged from about $400 to $415 per month or about $4,800 per year, all with the use of a … In August 2011, Pearson and colleagues published 3-year results from a 4-year, multicenter, randomized … Duration-1 three- year and Duration-3 84-week data presented at ADA 2011. [internet].

419. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - This report is being generated twice a year. … Although out-of- pocket expenses for phentermine-topiramate are estimated at $1,000–$2,000 per year, … Authors reported the following: 26 Weight loss at one year in 27 subjects who completed the protocol … Weight loss in 8 subjects at one year post implantation and at 12 months post-explantation was 21.6 … levels of insulin, cholesterol, low-density lipoprotein, and triglycerides levels normalized at 1 year

420. Draft Comparative Effectiveness Review Appendicies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
     April 01, 2005 - A four-year audit of interventional treatment for atheromatous renal artery stenosis. … Survival following renal artery stent revascularization: four-year follow-up. … Stent placement in the renal artery: three-year experience with the Palmaz stent. … Treatment of renovascular hypertension: one year results of renal angioplasty. … Flexible tantalum stents for the treatment of renovascular hypertension: a 10-year experience.